13FPulse
AT

ATYR ATYR PHARMA INC

2026Q2 · CUSIP 002120202 · Sector: Healthcare & Biotech

Funds left

Funds are exiting, but the price is holding

Funds that own it
90
Institutions that reported holding it to the SEC
Net decrease in holders
20
Last quarter 110 → now 90
How unusual is that
Bottom 20%
Stronger than only 7% of US stocks
What the filings say, in one paragraph

90 funds held ATYR at the end of 2026Q2, down 20 from the quarter before. Buying has faded, though the price is holding up. On the business itself, return on equity is -124.6%. ATYR has had 3 buying rushes in its history, and the price moved -72.2% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2019Q3: holders=18 2019Q4: holders=17 2020Q1: holders=23 2020Q2: holders=24 2020Q3: holders=23 2020Q4: holders=22 2021Q1: holders=23 2021Q2: holders=28 2021Q3: holders=41 2021Q4: holders=47 2022Q1: holders=41 2022Q2: holders=36 2022Q3: holders=33 2022Q4: holders=36 2023Q1: holders=38 2023Q2: holders=41 2023Q3: holders=41 2023Q4: holders=46 2024Q1: holders=56 2024Q2: holders=47 2024Q3: holders=55 2024Q4: holders=77 2025Q1: holders=87 2025Q2: holders=110 2025Q3: holders=103 2025Q4: holders=83 2026Q1: holders=110 2026Q2: holders=90 -27 -13.5 +0 +13.5 +27 1566116 19Q320Q221Q121Q422Q323Q224Q124Q425Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 3 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 20%
2025Q2 Top 20% -84.7% -79.8%
2021Q3 Top 20% -39.9% -64.6%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
52
Change in large funds
-11
Total value they hold
$23M
Funds buying for the first time
17
Funds that sold out entirely
37
Price change that quarter
Funds holding puts (bearish)
6
Funds holding calls (bullish)
4

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
EPS (TTM)
$-0.63
EPS YoY
Revenue (TTM)
Revenue YoY
Net margin
ROE
-124.6%
Debt ratio
30.1%
FCF (TTM)
-$55M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.42 2021-12-31: EPS -0.20 2022-03-31: EPS -0.44 2022-06-30: EPS -0.44 2022-09-30: EPS -0.46 2022-12-31: EPS -0.26 2023-03-31: EPS -0.29 2023-06-30: EPS -0.22 2023-09-30: EPS -0.20 2023-12-31: EPS -0.23 2024-03-31: EPS -0.23 2024-06-30: EPS -0.23 2024-09-30: EPS -0.23 2024-12-31: EPS -0.17 2025-03-31: EPS -0.17 2025-06-30: EPS -0.22 2025-09-30: EPS -0.26 2025-12-31: EPS -0.15 2026-03-31: EPS -0.11 2026-06-30: EPS -0.11 -0.51 -0.25 0.00 20212022202320242025202606/26 EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-22M-10M2M 20162017201820192020202120222023202420252026
Latest quarter $-13M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.